Journal
JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/jcm10092040
Keywords
diabetic kidney disease; cardiovascular disease; non-alcoholic fatty liver disease
Categories
Ask authors/readers for more resources
Non-alcoholic fatty liver disease is closely associated with cardiovascular disease and chronic kidney disease, sharing common pathophysiological processes. It is particularly prevalent in patients with type 2 diabetes, underscoring the importance of early diagnosis and treatment to reduce the burden of adverse outcomes.
Non-alcoholic fatty liver disease is a highly prevalent disease worldwide with a renowned relation to cardiovascular disease and chronic kidney disease. These diseases share a common pathophysiology including insulin resistance, oxidative stress, chronic inflammation, dysbiosis and genetic susceptibilities. Non-alcoholic fatty liver disease is especially prevalent and more severe in type 2 diabetes. Patients with non-alcoholic fatty liver disease should have liver fibrosis assessment in order to identify those at the highest risk of adverse outcomes so that appropriate management strategies can be implemented. Early diagnosis and treatment of non-alcoholic fatty liver disease could ameliorate the burden of cardiovascular disease and chronic kidney disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available